Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
18–79
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients diagnosed with Restless Legs Syndrome (RLS) with symptoms such as: uncomfortable or "creepy-crawly" sensations in your legs, overwhelming urge to move your legs to relieve these sensations, sensations go away when you move your legs, or trouble falling asleep or staying asleep because of these symptoms.
Patients must give written informed consent prior to any specific study procedures.
You may not be if
Patients who suffer from narcolepsy, sleep terror disorder, sleepwalking disorder, or a breathing related sleep disorder.
Patients diagnosed with renal failure (end-stage renal disease) iron deficient anemia or pregnancy.
Patients suffering from other movement disorders (i.e. Parkinson's Disease).
Patients who have medical conditions such as diabetes, peripheral neuropathy, rheumatoid arthritis, or fibromyalgia syndrome.
Participation in any clinical drug or device trial in the last three months.
Clareo Health | A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome
